Medicine recalls
|
| |
| Batch Recall of Maxilin Powder for Solution for Infusion 500mg |
| |
The Department of Health (DH) today (10 December) endorsed a licensed drug wholesaler, Hong Kong Medical Supplies Ltd. (HKMS), to recall one batch (batch number: 24F040) of the product, namely Maxilin Powder for Solution for Infusion 500mg (Hong Kong Registration number: HK-65860) from the market as a precautionary measure due to the potential quality issue.
The DH received notification from HKMS that the overseas manufacturer of the concerned product is recalling the above batch of Maxilin Powder for Solution for Infusion 500mg from the market because of misrepresentation of its active pharmaceutical ingredient (API) manufacturing site which is breaking the traceability of the supply chain of the API source. HKMS therefore is voluntarily recalling the affected batch from the market.
The above product contains clarithromycin which is a prescription medicine used for the treatment of bacterial infections. According to HKMS, the affected batch had been imported into Hong Kong and supplied to Hospital Authority and private hospitals.
HKMS has set up a hotline 2806 3112 to answer related enquiries.
So far, the DH has not received any adverse reaction report in connection with the product. The DH will closely monitor the recall.
Patients should not stop taking the products without talking to your doctors. If in doubt, please consult the healthcare professionals immediately.
Ends/ Wednesday, December 10, 2025 |
| |
